Bio Key International Inc (BKYI) Stock Price & Analysis

Bio Key International Inc (BKYI) rose 0.00% to USD 4.14 as of June 10, 2026 at 09:42 UTC, according to Nexqual real-time market data.

BKYI last closed at USD 4.14; the session ranged USD 4.14–4.25 on volume of 1,627 shares. Market capitalization is $4.49M, with a 52-week range of USD 3.1–19.7 (PNK). Source: Nexqual, June 10, 2026 at 09:42 UTC.

Key Statistics (as of June 10, 2026 at 09:42 UTC)

PriceUSD 4.14
Change▲ 0.00% (up)
Previous CloseUSD 4.14
OpenUSD 4.25
Day RangeUSD 4.14 – 4.25
52-Week RangeUSD 3.1 – 19.7
Volume1,627 shares
Market Cap$4.49M
ExchangePNK

Technical Analysis (BKYI)

Nexqual's technical model rates BKYI "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 09:42 UTC.

Overall SignalSTRONG SELL
RSI (14)38.16 (neutral)
vs SMA50Below (USD 5.15)
MACD-0.26 (negative)

Analyst Ratings (BKYI)

Wall Street analysts rate BKYI "None" based on 1 analysts, with a mean price target of USD 20 (range USD 20–20), per Nexqual as of June 10, 2026 at 09:42 UTC.

Consensus RatingNone
Analyst Count1
Mean TargetUSD 20
High TargetUSD 20
Low TargetUSD 20
Buy / Hold / Sell1 / 0 / 0

Earnings (BKYI)

EPS EstimateUSD -0.8
Revenue Estimate$2.20M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.13 vs est -0.6 ▲ beat
2025-09-30USD -1.49 vs est -1.2 ▼ miss
2025-06-30USD -2 vs est -1.5 ▼ miss

Source: Nexqual, June 10, 2026 at 09:42 UTC.

Financials & Fundamentals (BKYI)

Total Revenue$6.63M
Revenue Growth (YoY)+33.50%
Gross Margin+77.84%
Operating Margin-5.49%
Profit Margin-60.58%
ROE-53.73%
Debt / Equity9.51
Current Ratio1.41
Total Cash$2.25M
Total Debt$706,695

Source: Nexqual, June 10, 2026 at 09:42 UTC.

Financial Health Score (BKYI)

Nexqual rates Bio Key International Inc's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:42 UTC.

GrowthCritical — Revenue -100% YoY (annual), sharp decline
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetStrong — $2M cash, no debt
Cash FlowMixed — No data
EfficiencyCritical — ROE -54%, ROA -21.4%

Ownership (BKYI)

Insider Ownership+11.39%
Institutional Ownership+7.26%
Shares Outstanding1.09M
Float9.85M
Short % of Float+1.88%

Source: Nexqual, June 10, 2026 at 09:42 UTC.

Leadership (BKYI)

Bio Key International Inc is led by Michael W. DePasquale (age 70), Chairman & CEO, per Nexqual as of June 10, 2026 at 09:42 UTC.

Chairman & CEOMichael W. DePasquale (age 70)
MD of Hong Kong & Vice-Chairman of the BoardKwok Fong Wong (age 62)
Chief Financial OfficerCecilia C. Welch (age 65)
Chief Technology OfficerMira K. LaCous (age 63)
Managing Director of AfricaAkintunde Carlton Jeje

Major Backers & Investors (BKYI)

Notable institutional backers of Bio Key International Inc include Fidelity, Citigroup Inc., Virtu Financial LLC, according to Nexqual as of June 10, 2026 at 09:42 UTC.

Active Investors

InvestorStake
Fidelity2.55%
Citigroup Inc.0.46%
Virtu Financial LLC0.19%
Susquehanna International Group, LLP0.16%

Index Funds (Passive)

FundStake
Geode Capital2.72%
Vanguard Group0.64%

Source: Nexqual, June 10, 2026 at 09:42 UTC.

From Bio Key International Inc's Latest SEC 10-K Filing (filed 2025-04-23)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OLOXOlenox Industries Inc.USD 7.84▲ 3.57%
BOXLBoxlight CorporationUSD 0.77▲ 13.85%
PHIOPhio Pharmaceuticals Corp.USD 1.08▲ 1.89%
SPCBSuperCom, Ltd.USD 9.74▼ 6.35%
WORXSCWorx Corp.USD 0.26▼ 24.43%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:42 UTC. This page is informational and not investment advice.